Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Carbonic Anhydrase Inhibitors on Pulmonary Response to Hypoxia
NCT02760121Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- May 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Altitude sickness (AMS) comparing Acetazolamide, Methazolamide and Placebo (3 arms). Primary endpoints: Change in ventilation at 60 minutes and Change in pulmonary artery pressure at 60 minutes. Started May 2016; status: completed.
02
Drugs
acetazolamidemethazolamide
03
Conditions
Altitude sickness (AMS)
Beyond the preview
Go deeper on NCT02760121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760121.